InsiderPulseNo transactions found.
| Date | Member | Chamber | Type | Amount |
|---|---|---|---|---|
| 2026-01-29 | David J. Taylor(R-OH02) | house | Sale | $1,001 - $15,000 |
| 2025-08-07 | David J. Taylor(R-OH02) | house | Purchase | $1,001 - $15,000 |
| 2025-06-11 | Lisa McClain(R-MI09) | house | Sale | $1,001 - $15,000 |
| 2025-06-10 | Lisa McClain(R-MI09) | house | Sale | $1,001 - $15,000 |
| 2025-05-12 | Jefferson Shreve(R-IN06) | house | Sale | $15,001 - $50,000 |
No financial data available for VRTX.
Company may not file with SEC or CIK is unresolved.
Vertex projects 2026 revenue of $12.95B-$13.1B while targeting $500M-plus from non-CF products
Vertex Pharmaceuticals Incorporated (VRTX) Q1 2026 Earnings Call Transcript
Vertex Pharmaceuticals Q1 Earnings Call Highlights
Vertex (VRTX) Q1 2026 Earnings Call Transcript